Clinical Research Directory
Browse clinical research sites, groups, and studies.
Oral Dexmedetomidine in Pediatric MRI
Sponsor: Soroush Merchant
Summary
The objective of this preliminary study is to assess the utility of oral dexmedetomidine as the sole sedative agent in pediatric population undergoing MRI.
Official title: Utility of Oral Dexmedetomidine as the Sole Sedative Agent in Pediatric Population Undergoing MRI
Key Details
Gender
All
Age Range
3 Years - 6 Years
Study Type
INTERVENTIONAL
Enrollment
18
Start Date
2026-06-01
Completion Date
2027-09
Last Updated
2026-04-08
Healthy Volunteers
Yes
Conditions
Interventions
Dexmedetomidine
Participants will receive oral dexmedetomidine as the sole sedative agent for undergoing MRI
General Anesthesia (control group)
Participants will receive general anesthesia for their MRI
Locations (1)
Children's Mercy Hospital
Kansas City, Missouri, United States